Which patients pursue fertility preservation treatments? A multicenter analysis of the predictors of fertility preservation in women with breast cancer

Fertility and Sterility

Volumn 97, Issue 3, 2012, Pages 671-676

  Kim, Jayeon ^a   Oktay, Kutluk ^b   Gracia, Clarisa ^c   Lee, Sanghoon ^b   Morse, Christopher ^c   Mersereau, Jennifer E ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

breast cancer; Fertility preservation; neoadjuvant chemotherapy; predictors

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADULT; AGE; ARTICLE; BODY MASS; BREAST CANCER; CANCER PATIENT; CANCER SURVIVAL; DISEASE SEVERITY; FEMALE; FERTILITY; HUMAN; INCOME; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REPRODUCTIVE PROCEDURES;

ACADEMIC MEDICAL CENTERS; ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; BODY MASS INDEX; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; FEMALE; FERTILITY PRESERVATION; HUMANS; INCOME; INFERTILITY, FEMALE; LOGISTIC MODELS; NEOADJUVANT THERAPY; NEOPLASM STAGING; ODDS RATIO; PATIENT ACCEPTANCE OF HEALTH CARE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; UNITED STATES;

EID: 84857791465     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2011.12.008     Document Type: Article

References (27)

1. S.J. Lee, L.R. Schover, A.H. Partridge, P. Patrizio, W.H. Wallace, and K. Hagerty American Society of Clinical Oncology recommendations on fertility preservation in cancer patients J Clin Oncol 24 2006 2917 2931
2. Ethics Committee of the American Society for Reproductive Medicine Fertility preservation and reproduction in cancer patients Fertil Steril 83 2005 1622 1628
3. B. Lawrenz, J. Jauckus, M.S. Kupka, T. Strowitzki, and M. von Wolff Fertility preservation in >1,000 patients: patient's characteristics, spectrum, efficacy and risks of applied preservation techniques Arch Gynecol Obstet 283 2011 651 656
4. R.L. Street Jr., B. Voigt, C. Geyer Jr., T. Manning, and G.P. Swanson Increasing patient involvement in choosing treatment for early breast cancer Cancer 76 1995 2275 2285
5. U. Balthazar, M.A. Fritz, and J.E. Mersereau Fertility preservation: a pilot study to assess previsit patient knowledge quantitatively Fertil Steril 95 2011 1913 1916
6. L. Campo-Engelstein Consistency in insurance coverage for iatrogenic conditions resulting from cancer treatment including fertility preservation J Clin Oncol 28 2010 1284 1286
7. B. Thewes, B. Meiser, J. Rickard, and M. Friedlander The fertility- and menopause-related information needs of younger women with a diagnosis of breast cancer: a qualitative study Psychooncology 12 2003 500 511
8. D. Litaker, S.A. Flocke, J.P. Frolkis, and K.C. Stange Physicians' attitudes and preventive care delivery: insights from the DOPC study Prev Med 40 2005 556 563
9. Melissa Data. Available at: http://www.melissadata.com/lookups/taxzip. asp. Accessed on April 5, 2011.
10. P.G. Moorman, B.A. Jones, R.C. Millikan, I.J. Hall, and B. Newman Race, anthropometric factors, and stage at diagnosis of breast cancer Am J Epidemiol 153 2001 284 291
11. S.V. Liu, L. Melstrom, K. Yao, C.A. Russell, and S.F. Sener Neoadjuvant therapy for breast cancer J Surg Oncol 101 2010 283 291
12. J. Kao, S.D. Conzen, N.T. Jaskowiak, D.H. Song, W. Recant, and R. Singh Concomitant radiation therapy and paclitaxel for unresectable locally advanced breast cancer: results from two consecutive phase I/II trials Int J Radiat Oncol Biol Phys 61 2005 1045 1053
13. C. Lohrisch, C. Paltiel, K. Gelmon, C. Speers, S. Taylor, and J. Barnett Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer J Clin Oncol 24 2006 4888 4894
14. S. Cold, M. During, M. Ewertz, A. Knoop, and S. Moller Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG) Br J Cancer 93 2005 627 632
15. K. Oktay, A. Hourvitz, G. Sahin, O. Oktem, B. Safro, and A. Cil Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy J Clin Endocrinol Metab 91 2006 3885 3890
16. S. Lee, S. Ozkavukcu, E. Heytens, F. Moy, and K. Oktay Value of early referral to fertility preservation in young women with breast cancer J Clin Oncol 28 2010 4683 4686
17. A.A. Azim, M. Costantini-Ferrando, and K. Oktay Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study J Clin Oncol 26 2008 2630 2635
18. T.A. Buchholz, K.K. Hunt, G.J. Whitman, A.A. Sahin, and G.N. Hortobagyi Neoadjuvant chemotherapy for breast carcinoma: multidisciplinary considerations of benefits and risks Cancer 98 2003 1150 1160
19. D.A. Mankoff, L.K. Dunnwald, J.R. Gralow, G.K. Ellis, A. Charlop, and T.J. Lawton Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy J Nucl Med 43 2002 500 509
20. G. von Minckwitz, S. Kummel, P. Vogel, C. Hanusch, H. Eidtmann, and J. Hilfrich Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomized GeparTrio study J Natl Cancer Inst 100 2008 552 562
21. G.P. Manga, P.K. Shahi, M.M. Urena, R.Q. Pereira, M.I. Plaza, and Y.I. Peron Phase II study of neoadjuvant treatment with doxorubicin, docetaxel, and capecitabine (ATX) in locally advanced or inflammatory breast cancer Breast Cancer 17 2010 205 211
22. L.R. Schover, K. Brey, A. Lichtin, L.I. Lipshultz, and S. Jeha Oncologists' attitudes and practices regarding banking sperm before cancer treatment J Clin Oncol 20 2002 1890 1897
23. K. Villman, J.F. Ohd, E. Lidbrink, L. Malmberg, B. Lindh, and C. Blomqvist A phase II study of epirubicin, cisplatin and capecitabine as neoadjuvant chemotherapy in locally advanced or inflammatory breast cancer Eur J Cancer 43 2007 1153 1160
24. S. Lee, E. Heytens, F. Moy, S. Ozkavukcu, and K. Oktay Determinants of access to fertility preservation in women with breast cancer Fertil Steril 95 2011 1932 1936
25. A. Makris, T.J. Powles, S.E. Ashley, J. Chang, T. Hickish, and V.A. Tidy A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer Ann Oncol 9 1998 1179 1184
26. B. Fisher, J. Bryant, N. Wolmark, E. Mamounas, A. Brown, and E.R. Fisher Effect of preoperative chemotherapy on the outcome of women with operable breast cancer J Clin Oncol 16 1998 2672 2685
27. D. Mauri, N. Pavlidis, and J.P. Ioannidis Neoadjuvant vs. adjuvant systemic treatment in breast cancer: a meta-analysis J Natl Cancer Inst 97 2005 188 194